COMMUNIQUÉS West-GlobeNewswire

Stockholm Patent and Market court resolution of dispute over C-RAD’s claim for Beamocular patent
26/07/2019
The Stockholm Patent and Market court confirmed C-RAD’s entitlement to the patent application “Ionizing radiation detecting device” in its verdict published today. C-RAD filed a patent entitlement lawsuit in May 2017 [...]
Axogen Announces Publication of the 100th Peer-Reviewed Clinical Paper Featuring its Product Portfolio for Peripheral Nerve Repair
26/07/2019
Publications provide evidence of positive outcomes with Axogen’s products in sensory, mixed and motor nerves, and in short and long gap nerve injuries across an expanding set of applications ALACHUA, Fla., July 26, 2019 [...]
Iovance Biotherapeutics to Host Second Quarter 2019 Financial Results Conference Call and Webcast on Thursday, August 1, 2019
26/07/2019
SAN CARLOS, Calif., July 26, 2019 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL [...]
GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX™ (cannabidiol oral solution) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy
26/07/2019
If approved cannabidiol oral solution will be the first plant-derived cannabis-based medicine to be approved in Europe for the treatment of any form of epilepsy GW’s cannabidiol oral solution contains highly purified, [...]
GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX™ (cannabidiol oral solution) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy
26/07/2019
If approved cannabidiol oral solution will be the first plant-derived cannabis-based medicine to be approved in Europe for the treatment of any form of epilepsy GW’s cannabidiol oral solution contains highly purified, [...]
Pixium Vision publishes its 2019 Interim Financial Report
26/07/2019
Pixium Vision publishes its 2019 Interim Financial Report Attachment H1 2019-Pixium-Interim financial report
Pixium Vision met à disposition son Rapport Financier Semestriel 2019
26/07/2019
Pixium Vision met à disposition son Rapport Financier Semestriel 2019 Pièce jointe 1S 2019-Pixium-Rapport Financier Semestriel
Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company
26/07/2019
Transaction to Create Nasdaq-listed Biotechnology Company Focused on Advancing NeuroBo’s Clinical-Stage Pipeline NeuroBo Poised to Advance Lead Drug Candidate into Phase 3 Trials for Neuropathic Pain Indications NeuroBo [...]
ASLAN Pharmaceuticals Names Industry Veteran and Current Board Member Andrew Howden to Additional Role of Chairman
26/07/2019
SINGAPORE, July 26, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today announced that Andrew Howden has been elected as non [...]
Motif Bio Confirms Meeting Date with U.S. FDA regarding Iclaprim
26/07/2019
NEW YORK, July 26, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announced today that the U.S. Food & Drug [...]
Motif Bio Confirms Receipt of Deficiency Notice from Nasdaq
26/07/2019
NEW YORK, July 26, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/Nasdaq: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that it has received a deficiency [...]
ObsEva SA Reports Positive Feedback from Independent Data Monitoring Committee for PROLONG Part B with OBE022
26/07/2019
Geneva, Switzerland and Boston, MA – July 26, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Janssen reports positive top-line Phase 3 results for ponesimod in adults with relapsing multiple sclerosis
26/07/2019
Data are part of the OPTIMUM study comparing the efficacy and safety of ponesimod and Aubagio ® in adults with relapsing multiple sclerosis Idorsia Pharmaceuticals Ltd, J&J and Actelion Pharmaceuticals Ltd have a [...]
Geocann Appoints Medical and Scientific Advisory Board to Expand Its Leadership Position in Research and Innovation
26/07/2019
The prestigious group is comprised of a multidisciplinary collective with decades of well-documented and published work as well as prominent careers focused on advancing the therapeutic benefits of science-backed [...]
MediPharm Labs Announces Trading Date on the Toronto Stock Exchange
25/07/2019
TORONTO, July 25, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, [...]
Aptevo Therapeutics Reports Continued Progress In APVO210 and APVO436 Clinical Trials
25/07/2019
Completes Dosing in Single Ascending Dose (SAD) Phase 1 Study of APVO210 Receives Approval to Begin APVO210 Multiple Ascending Dose (MAD) Study Preliminary Data Suggest that Single Doses of APVO210 Appear to be Safe and [...]
Neuronetics to Present at the 39th Annual Canaccord Genuity Growth Conference
25/07/2019
MALVERN, Pa., July 25, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for [...]
Natus Medical Announces Second Quarter 2019 Financial Results
25/07/2019
Second quarter revenue of $125.5 million exceeded expectations Second quarter GAAP earnings per share of $0.12 Second quarter non-GAAP earnings per share of $0.34 exceeded expectations NASDAQ ticker symbol change to “ [...]
Shineco, Inc. to Launch Hemp Based Cosmeceutical Products in August
25/07/2019
BEIJING, July 25, 2019 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and [...]

Pages